Generic Name:
Project Status:
Therapeutic Area:
Supratentorial glioblastoma (GBM)
Novocure Canada Inc.
Call for patient/clinician input open:
Brand Name:
Project Line:
Health Technology Review
Project Sub Line:
Optimal Use
Project Number:
Call for patient/clinician input closed:

To enhance the quality and relevance of this work, CADTH is engaging people with extensive personal and/or professional experience within the Canadian health system.

CADTH Call for Statements of Interest

End of feedback period: January, 2024


Statements of Interest

Key Milestones2
Call for patient/clinician input openJuly 13, 2023
Call for patient/clinician input closedSeptember 1, 2023
Submission receivedAugust 18, 2023
Submission acceptedSeptember 1, 2023
Review initiatedSeptember 5, 2023
Draft CADTH review report(s) provided to sponsor for comment
Deadline for sponsors comments
CADTH review report(s) and responses to comments provided to sponsor
Expert committee meeting (initial)
Draft recommendation issued to sponsor
Draft recommendation posted for stakeholder feedback
End of feedback period